In particular, a case-control study conducted in France found significantly decreased BRCA1 methylation in peripheral blood cells of 51 sporadic ovarian cancer cases compared with 349 healthy female controls [40]. This evidence concerns the gene BRCA1 and ovarian carcinoma.